AUTUMN RITZ: Open Payments
NPI 1487380184 · TINLEY PARK, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,966 in 78 payments from 30 companies in 2025. Trend: 2023 $751 · 2024 $2,180 · 2025 $1,966
Food & beverage: $1,734Education: $232
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 8 | $239 |
| Daiichi Sankyo Inc. | 6 | $232 |
| Celgene Corporation | 7 | $218 |
| PFIZER INC. | 5 | $125 |
| Janssen Biotech, Inc. | 3 | $111 |
| ABBVIE INC. | 6 | $108 |
| Eisai Inc. | 5 | $107 |
| Genentech USA, Inc. | 4 | $95 |
| Novartis Pharmaceuticals Corporation | 5 | $85 |
| SOBI, INC | 3 | $53 |
Products named: ENHERTU, REBLOZYL, Lenvima, PADCEV, KISQALI, TECVAYLI, ELAHERE, CALQUENCE.
Industry payments across IL — which companies pay providers there.
